Rafferty Asset Management, LLC Abbott Laboratories Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 176,470 shares of ABT stock, worth $20.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

176,470

Previous 189,200 6.73%

Holding current value

$20.3 Million

Previous $19.7 Million 2.34%

% of portfolio

0.07%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $1.27 Million - $1.5 Million	-12,730 Reduced 6.73%	176,470 $20.1 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $1.01 Million - $1.13 Million	10,042 Added 5.61%	189,200 $19.7 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $274,895 - $303,609	2,510 Added 1.42%	179,158 $20.4 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $398,820 - $488,188	-4,422 Reduced 2.44%	176,648 $19.4 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $1.22 Million - $1.47 Million	12,809 Added 7.61%	181,070 $17.5 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $1.24 Million - $1.38 Million	12,267 Added 7.86%	168,261 $18.3 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $579,029 - $681,551	5,978 Added 3.98%	155,994 $15.8 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $5.35 Million - $6.28 Million	56,324 Added 60.12%	150,016 $16.5 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $4.95 Million - $5.74 Million	51,209 Added 120.54%	93,692 $9.07 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $1.18 Million - $1.43 Million	-11,568 Reduced 21.4%	42,483 $4.62 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $613,883 - $748,591	-5,384 Reduced 9.06%	54,051 $6.4 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $336,307 - $411,790	2,911 Added 5.15%	59,435 $8.37 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $2.01 Million - $2.22 Million	17,206 Added 43.76%	56,524 $6.68 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $398,722 - $469,353	3,769 Added 10.6%	39,318 $4.56 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $344,369 - $405,719	3,164 Added 9.77%	35,549 $206 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $254,310 - $277,125	-2,422 Reduced 6.96%	32,385 $3.55 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $1.04 Million - $1.27 Million	-11,396 Reduced 24.67%	34,807 $3.79 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $2.27 Million - $2.91 Million	29,697 Added 179.92%	46,203 $4.22 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $1.96 Million - $2.87 Million	-31,221 Reduced 65.42%	16,506 $1.3 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $3.5 Million - $3.89 Million	44,527 Added 1391.47%	47,727 $4.15 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $500,287 - $542,467	-6,113 Reduced 65.64%	3,200 $268,000
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $167,478 - $195,330	-2,298 Reduced 19.79%	9,313 $783,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $768,880 - $929,576	11,611 New	11,611 $928,000
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $197,991 - $224,295	-3,020 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $183,646 - $221,547	3,020 New	3,020 $222,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $2.77 Million - $3.06 Million	-48,154 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $2.71 Million - $3.06 Million	48,154 New	48,154 $2.89 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Abbott Laboratories Transaction History